Cécile Denis is director of research at INSERM (Institut National de la Sante et de la Recherche Medicale) in Kremlin-Bicetre Hospital next to Paris, France. After completing her PhD in 1993 at University of Paris, she spent the next seven years working at Harvard Medical School in Boston. Back in France, she obtained a permanent position at INSERM and developed her own research team.
Since 2010, she is the director of Inserm Unit 1176, an Inserm laboratory covering a large aspect of hemostasis research from platelet function to coagulation proteins and involved in the development of new therapeutics for bleeding disorders. Her long-standing personal interest has been on von
Willebrand factor and von Willebrand disease and development of animal models.
She received prizes from the French Academy of Sciences in 2006 and from the International Society of Thrombosis and Haemostasis in 2017. She has also received the French Legion d’Honneur in 2012. She has published more than 130 papers in the field of Thrombosis and Haemostasis and is inventor on 11 related patents.